Posted on April 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on April 1, 20224/1/22
What You Need to Know as the European Union Embarks on Joint Health Technology Assessment (HTA)
Posted on March 23, 20223/23/22
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
Posted on March 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on January 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on January 20, 20221/20/22
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Posted on December 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on December 21, 202112/21/21
Launch Sequencing and Market Prioritization in an Evolving Global Market
Posted on December 6, 202112/6/21
Considering Commercial Success During Clinical Development: Maintaining a Global Perspective
Posted on November 9, 202111/9/21